Abstract
This review article encompasses the historical perspective of androgen deprivation therapy by first reviewing the early research conducted by Huggins and Hodge, followed by a cellular biological discussion of androgen receptors in prostate cancer (PCa) physiology, leading to a subsequent discussion of the risk and potential therapeutic role of testosterone therapy in localized, oligometastatic, and metastatic PCa.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have